MARKETS / NASC
WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES · SMALL CAP
Can B Corp. NASC
9 fiscal years on record · USD · FY2023 reported · SEC filings only
Growth
USD 2.2M
Revenue, FY2023 · full 9-year series below
Revenue $M
Net income $M
FY2023 · Revenue 2.2 · Net income -9.7
Compound annual growth
Revenue compounded at +26.4% a year over five years.
Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.
Profitability
−452 cents
lost on every revenue dollar
Operating margin
Net margin
FY2023 · Operating -347.3% · Net -451.7%
ROE
FY2023 · ROE -1148.3%
Each USD of equity lost 1148 cents this year.
The 9-year record
9 fiscal years
Every figure from documents filed with the SEC · USD
EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.
row low → row highnegative
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue $B | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Operating income $B | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | · | · |
| EBITDA $B | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | · | · |
| Income tax $B | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | · | −0.0 | −0.0 | −0.0 |
| Net income $B | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 |
| Free cash flow $B | −0.0 | · | −0.0 | −0.0 | −0.0 | −0.0 | · | · | · |
| EPS, diluted $ | −0.77 | −4.18 | −9.06 | −37.68 | −2.20 | −0.01 | 0.00 | 0.00 | −0.02 |
| Dividend / sh $ | · | · | · | · | · | · | · | · | · |
| Payout % | · | · | · | · | · | · | · | · | · |
| ROE % | −1148.3 | −358.9 | −343.0 | −218.5 | −116.4 | −467.6 | · | · | −3477.4 |
| Shares out B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.44 | 0.23 | 0.15 | 0.15 |
Slide the table for earlier years · "·" marks a figure not available in our data for that year.
Provenance
Company facts, as filed
How we verify · 0 failures in 41 reconciliationsAUDITED
Reconciled in 9 of 19 fiscal years. 54 checks could not be computed.
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures
ActivityWholesale-Drugs, Proprietaries & Druggists' Sundries
Listed onnot stated in the filings
Incorporated inFlorida
Fiscal year endsDecember 31
SEC categorysmaller reporting company
Data on record since2015